It’s drug pricing palooza!
Welcome to the week in review in prescription drug pricing.
1. LOL Pfizer
Pfizer spun its January price hikes as impacting an itsy bitsy portion of its drugs. Too bad the 41 drugs it hiked represent half the pharma giant’s revenue. — (Axios)
2. Johnny Depp would be proud.
PhRMA is running ghost ships now. — (WaPo)
3. All the hearings
The Republican-controlled Senate and Democratic-controlled House are kicking off 2019 by lighting up out-of-control drug pricing with Senate Finance and House Oversight committee hearings Tuesday.— (The Hill)
4. It’s a thing. A 2020 thing.
Potential presidential candidates are staking claims in the drug pricing debate. Smart move,
The drug lobby’s arguments against holding down prices in Medicare Part B just don’t add up. — (STAT)